table of content
1 Introduction to Research & Analysis Reports
1.1 Cell and Gene Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cell and Gene Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cell and Gene Therapy Overall Market Size
2.1 Global Cell and Gene Therapy Market Size: 2022 VS 2030
2.2 Global Cell and Gene Therapy Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cell and Gene Therapy Players in Global Market
3.2 Top Global Cell and Gene Therapy Companies Ranked by Revenue
3.3 Global Cell and Gene Therapy Revenue by Companies
3.4 Top 3 and Top 5 Cell and Gene Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cell and Gene Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cell and Gene Therapy Players in Global Market
3.6.1 List of Global Tier 1 Cell and Gene Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Cell and Gene Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cell and Gene Therapy Market Size Markets, 2022 & 2030
4.1.2 Rare Diseases
4.1.3 Oncology
4.1.4 Hematology
4.1.5 Cardiovascular
4.1.6 Ophthalmology
4.1.7 Neurology
4.1.8 Other Therapeutic Classes
4.2 By Type - Global Cell and Gene Therapy Revenue & Forecasts
4.2.1 By Type - Global Cell and Gene Therapy Revenue, 2018-2023
4.2.2 By Type - Global Cell and Gene Therapy Revenue, 2024-2030
4.2.3 By Type - Global Cell and Gene Therapy Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cell and Gene Therapy Market Size, 2022 & 2030
5.1.2 Pharmaceutical and Biotechnology Companies
5.1.3 Research and Academic Institutions
5.1.4 Contract Research Organizations (CROs)
5.1.5 Hospital
5.1.6 Others
5.2 By Application - Global Cell and Gene Therapy Revenue & Forecasts
5.2.1 By Application - Global Cell and Gene Therapy Revenue, 2018-2023
5.2.2 By Application - Global Cell and Gene Therapy Revenue, 2024-2030
5.2.3 By Application - Global Cell and Gene Therapy Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Cell and Gene Therapy Market Size, 2022 & 2030
6.2 By Region - Global Cell and Gene Therapy Revenue & Forecasts
6.2.1 By Region - Global Cell and Gene Therapy Revenue, 2018-2023
6.2.2 By Region - Global Cell and Gene Therapy Revenue, 2024-2030
6.2.3 By Region - Global Cell and Gene Therapy Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Cell and Gene Therapy Revenue, 2018-2030
6.3.2 US Cell and Gene Therapy Market Size, 2018-2030
6.3.3 Canada Cell and Gene Therapy Market Size, 2018-2030
6.3.4 Mexico Cell and Gene Therapy Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Cell and Gene Therapy Revenue, 2018-2030
6.4.2 Germany Cell and Gene Therapy Market Size, 2018-2030
6.4.3 France Cell and Gene Therapy Market Size, 2018-2030
6.4.4 U.K. Cell and Gene Therapy Market Size, 2018-2030
6.4.5 Italy Cell and Gene Therapy Market Size, 2018-2030
6.4.6 Russia Cell and Gene Therapy Market Size, 2018-2030
6.4.7 Nordic Countries Cell and Gene Therapy Market Size, 2018-2030
6.4.8 Benelux Cell and Gene Therapy Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Cell and Gene Therapy Revenue, 2018-2030
6.5.2 China Cell and Gene Therapy Market Size, 2018-2030
6.5.3 Japan Cell and Gene Therapy Market Size, 2018-2030
6.5.4 South Korea Cell and Gene Therapy Market Size, 2018-2030
6.5.5 Southeast Asia Cell and Gene Therapy Market Size, 2018-2030
6.5.6 India Cell and Gene Therapy Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Cell and Gene Therapy Revenue, 2018-2030
6.6.2 Brazil Cell and Gene Therapy Market Size, 2018-2030
6.6.3 Argentina Cell and Gene Therapy Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cell and Gene Therapy Revenue, 2018-2030
6.7.2 Turkey Cell and Gene Therapy Market Size, 2018-2030
6.7.3 Israel Cell and Gene Therapy Market Size, 2018-2030
6.7.4 Saudi Arabia Cell and Gene Therapy Market Size, 2018-2030
6.7.5 UAE Cell and Gene Therapy Market Size, 2018-2030
7 Cell and Gene Therapy Companies Profiles
7.1 Amgen Inc.
7.1.1 Amgen Inc. Company Summary
7.1.2 Amgen Inc. Business Overview
7.1.3 Amgen Inc. Cell and Gene Therapy Major Product Offerings
7.1.4 Amgen Inc. Cell and Gene Therapy Revenue in Global Market (2018-2023)
7.1.5 Amgen Inc. Key News & Latest Developments
7.2 bluebird bio, Inc.
7.2.1 bluebird bio, Inc. Company Summary
7.2.2 bluebird bio, Inc. Business Overview
7.2.3 bluebird bio, Inc. Cell and Gene Therapy Major Product Offerings
7.2.4 bluebird bio, Inc. Cell and Gene Therapy Revenue in Global Market (2018-2023)
7.2.5 bluebird bio, Inc. Key News & Latest Developments
7.3 Dendreon Pharmaceuticals LLC.
7.3.1 Dendreon Pharmaceuticals LLC. Company Summary
7.3.2 Dendreon Pharmaceuticals LLC. Business Overview
7.3.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Major Product Offerings
7.3.4 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Revenue in Global Market (2018-2023)
7.3.5 Dendreon Pharmaceuticals LLC. Key News & Latest Developments
7.4 Fibrocell Science, Inc.
7.4.1 Fibrocell Science, Inc. Company Summary
7.4.2 Fibrocell Science, Inc. Business Overview
7.4.3 Fibrocell Science, Inc. Cell and Gene Therapy Major Product Offerings
7.4.4 Fibrocell Science, Inc. Cell and Gene Therapy Revenue in Global Market (2018-2023)
7.4.5 Fibrocell Science, Inc. Key News & Latest Developments
7.5 Human Stem Cells Institute
7.5.1 Human Stem Cells Institute Company Summary
7.5.2 Human Stem Cells Institute Business Overview
7.5.3 Human Stem Cells Institute Cell and Gene Therapy Major Product Offerings
7.5.4 Human Stem Cells Institute Cell and Gene Therapy Revenue in Global Market (2018-2023)
7.5.5 Human Stem Cells Institute Key News & Latest Developments
7.6 Kite Pharma, Inc.
7.6.1 Kite Pharma, Inc. Company Summary
7.6.2 Kite Pharma, Inc. Business Overview
7.6.3 Kite Pharma, Inc. Cell and Gene Therapy Major Product Offerings
7.6.4 Kite Pharma, Inc. Cell and Gene Therapy Revenue in Global Market (2018-2023)
7.6.5 Kite Pharma, Inc. Key News & Latest Developments
7.7 Kolon TissueGene, Inc.
7.7.1 Kolon TissueGene, Inc. Company Summary
7.7.2 Kolon TissueGene, Inc. Business Overview
7.7.3 Kolon TissueGene, Inc. Cell and Gene Therapy Major Product Offerings
7.7.4 Kolon TissueGene, Inc. Cell and Gene Therapy Revenue in Global Market (2018-2023)
7.7.5 Kolon TissueGene, Inc. Key News & Latest Developments
7.8 Novartis AG
7.8.1 Novartis AG Company Summary
7.8.2 Novartis AG Business Overview
7.8.3 Novartis AG Cell and Gene Therapy Major Product Offerings
7.8.4 Novartis AG Cell and Gene Therapy Revenue in Global Market (2018-2023)
7.8.5 Novartis AG Key News & Latest Developments
7.9 Orchard Therapeutics plc.
7.9.1 Orchard Therapeutics plc. Company Summary
7.9.2 Orchard Therapeutics plc. Business Overview
7.9.3 Orchard Therapeutics plc. Cell and Gene Therapy Major Product Offerings
7.9.4 Orchard Therapeutics plc. Cell and Gene Therapy Revenue in Global Market (2018-2023)
7.9.5 Orchard Therapeutics plc. Key News & Latest Developments
7.10 Organogenesis Holdings Inc.
7.10.1 Organogenesis Holdings Inc. Company Summary
7.10.2 Organogenesis Holdings Inc. Business Overview
7.10.3 Organogenesis Holdings Inc. Cell and Gene Therapy Major Product Offerings
7.10.4 Organogenesis Holdings Inc. Cell and Gene Therapy Revenue in Global Market (2018-2023)
7.10.5 Organogenesis Holdings Inc. Key News & Latest Developments
7.11 Pfizer, Inc.
7.11.1 Pfizer, Inc. Company Summary
7.11.2 Pfizer, Inc. Business Overview
7.11.3 Pfizer, Inc. Cell and Gene Therapy Major Product Offerings
7.11.4 Pfizer, Inc. Cell and Gene Therapy Revenue in Global Market (2018-2023)
7.11.5 Pfizer, Inc. Key News & Latest Developments
7.12 RENOVA THERAPEUTICS
7.12.1 RENOVA THERAPEUTICS Company Summary
7.12.2 RENOVA THERAPEUTICS Business Overview
7.12.3 RENOVA THERAPEUTICS Cell and Gene Therapy Major Product Offerings
7.12.4 RENOVA THERAPEUTICS Cell and Gene Therapy Revenue in Global Market (2018-2023)
7.12.5 RENOVA THERAPEUTICS Key News & Latest Developments
7.13 Shanghai Sunway Biotech Co., Ltd.,
7.13.1 Shanghai Sunway Biotech Co., Ltd., Company Summary
7.13.2 Shanghai Sunway Biotech Co., Ltd., Business Overview
7.13.3 Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Major Product Offerings
7.13.4 Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Revenue in Global Market (2018-2023)
7.13.5 Shanghai Sunway Biotech Co., Ltd., Key News & Latest Developments
7.14 Sibiono GeneTech Co. Ltd.,
7.14.1 Sibiono GeneTech Co. Ltd., Company Summary
7.14.2 Sibiono GeneTech Co. Ltd., Business Overview
7.14.3 Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Major Product Offerings
7.14.4 Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Revenue in Global Market (2018-2023)
7.14.5 Sibiono GeneTech Co. Ltd., Key News & Latest Developments
7.15 Spark Therapeutics, Inc.
7.15.1 Spark Therapeutics, Inc. Company Summary
7.15.2 Spark Therapeutics, Inc. Business Overview
7.15.3 Spark Therapeutics, Inc. Cell and Gene Therapy Major Product Offerings
7.15.4 Spark Therapeutics, Inc. Cell and Gene Therapy Revenue in Global Market (2018-2023)
7.15.5 Spark Therapeutics, Inc. Key News & Latest Developments
7.16 Vericel Corporation
7.16.1 Vericel Corporation Company Summary
7.16.2 Vericel Corporation Business Overview
7.16.3 Vericel Corporation Cell and Gene Therapy Major Product Offerings
7.16.4 Vericel Corporation Cell and Gene Therapy Revenue in Global Market (2018-2023)
7.16.5 Vericel Corporation Key News & Latest Developments
7.17 ViroMed Co., Ltd.
7.17.1 ViroMed Co., Ltd. Company Summary
7.17.2 ViroMed Co., Ltd. Business Overview
7.17.3 ViroMed Co., Ltd. Cell and Gene Therapy Major Product Offerings
7.17.4 ViroMed Co., Ltd. Cell and Gene Therapy Revenue in Global Market (2018-2023)
7.17.5 ViroMed Co., Ltd. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
